Co-Authors
This is a "connection" page, showing publications co-authored by Alfredo Papa and Gianmaria Cammarota.
Connection Strength
0.368
-
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
Score: 0.222
-
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther. 1998 Jun; 12(6):539-43.
Score: 0.048
-
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
Score: 0.046
-
Clinical assessment of the relationship of Helicobacter pylori to gastroduodenal pathologies. A prospective analysis of 253 consecutive patients. Panminerva Med. 1995 Dec; 37(4):178-81.
Score: 0.040
-
Long-term follow-up of disappearance of gastric mucosa-associated lymphoid tissue after anti-Helicobacter pylori therapy. Am J Gastroenterol. 1997 Oct; 92(10):1849-52.
Score: 0.011